|About Us||Patients, Families & Visitors||For Health Professionals||Careers||Research & Training||Ways to Give|
Translational research provides a much needed bridge of communication between highly specialized research scientists and physicians. Researchers working in labs with microscopes and tissue samples and physicians who directly interact with patients speak very different languages. It is vital that cutting edge research arrives to physicians in a useable format. It is also essential that information gathered from physicians get to researchers.
The translational process involves identifying current significant research projects and taking the knowledge and learning of these studies and applying it directly to the patient level. Fundamentally, it puts valuable theories into practice - a progression absolutely necessary in finding a cure.
Translational research is central to the research strategy of the London Regional Cancer Program (LRCP). Our research program is linked to the University of Western Ontario and the London Health Sciences Centre research community, and is multi-disciplinary and multi-departmental.
The Pamela Greenaway-Kohlmeier Translational Breast Cancer Unit was named for Pamela Greenaway-Kohlmeier, daughter of Lawrence and Kay Greenaway and wife of Guy Kohlmeier. Pamela died of breast cancer at age 38, which led her family to form the Breast Cancer Society of Canada (BCSC) to raise funds for breast cancer research.
The Unit was created in 1998, through a partnership between the London Regional Cancer Program (LRCP) and a $1 million donation from the Breast Cancer Society of Canada to the LRCP. The BCSC renewed its commitment to the Unit in 2004 and again in 2009, and to date has donated/pledged over $5.2 million to support our work.
Other community groups have joined in supporting the Unit, including Alan Frew and the Rose in My Book group . Theresa Carriere and her OneRun team, the Southwestern Ontario Women's Charity Cashspiel, and Fore the Cure, Strokes for Cancer and the Belmont Golf Tournament. We are grateful for such strong community support for our Unit.
We would be delighted if you also want to support our Unit.
One of the goals of the Unit is to promote interactions between scientists and physicians throughout London and to facilitate "translation" of molecular, cellular or genetic research findings to improvements in diagnosis, treatment, or prevention of breast cancer.
To foster this interaction, the Unit sponsors monthly Translational Breast Cancer Research Seminars, which are open to all interested members of the London academic community. These are organized by Joanne Gribbon and LRCP, and provide a lively forum for communication and intereaction between scientists, physicians, graduate students, medical residents, and others interested in translational breast cancer research.
A major goal of the Translational Breast Cancer Research Unit is to encourage and support trainees who are carrying out translational breast cancer research. By encouraging bright trainees to focus their research attention in this area, we hope to increase the number of highly qualified researchers who are working to solve the problem of breast cancer.
Call for Applicants
APPLICATION DEADLINE: Friday, June 28, 2013
Recipients of Translational Breast Cancer Research Traineeship Program: Studentships
Translational Breast Cancer Research Unit:
Dr. Ann Chambers, Director by e-mail, or telephone at 519.685.8652
Dr. Alison Allan, Assistant Director by e-mail, or telephone at 519.685.8600 x 55134